Current Report Filing (8-k)

Date : 01/10/2019 @ 9:32PM
Source : Edgar (US Regulatory)
Stock : Heat Biologics, Inc. (MM) (HTBX)
Quote : 0.6069  -0.0431 (-6.63%) @ 12:59AM

Current Report Filing (8-k)

   

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 8-K

 

CURRENT REPORT


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (date of earliest event reported): January 10, 2019


Heat Biologics, Inc.

(Exact name of registrant as specified in charter)


Delaware

(State or other jurisdiction of incorporation)

 

001-35994

26-2844103

(Commission File Number)

(IRS Employer Identification No.)


801 Capitola Drive

Durham, NC  27713

(Address of principal executive offices and zip code)


(919) 240-7133

(Registrant’s telephone number including area code)

 

N/A

(Former Name and Former Address)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

 

 

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company  ¨

 


If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨

 

 

 




 

Item 8.01.  Other Events.

 

On January 10, 2019, Heat Biologics, Inc. (the Company ) issued a press release that provided a business update regarding the Company s ongoing efforts and plans for 2019.   


Item 9.01.  Financial Statements and Exhibits.


(d) Exhibits.


The following exhibit is filed with this Current Report on Form 8-K:


Exhibit Number

 

Description

 

 

 

99.1

 

Press Release of Heat Biologics, Inc. dated January 10, 2019

 

 

 









SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated:  January 10, 2019

HEAT BIOLOGICS, INC.

 

 

 

 

 

 

By:

/s/ Jeffrey Wolf

 

Name:

Jeffrey Wolf

 

Title:

Chairman, President and
Chief Executive Officer










EXHIBIT INDEX


Exhibit Number

 

Description

 

 

 

99.1

 

Press Release of Heat Biologics, Inc. dated January 10, 2019

 

 

 








HEAT BIOLOGICS, INC. (NASDAQ:HTBX)
Historical Stock Chart

1 Year : From Jul 2018 to Jul 2019

Click Here for more HEAT BIOLOGICS, INC. Charts.

HEAT BIOLOGICS, INC. (NASDAQ:HTBX)
Intraday Stock Chart

Today : Sunday 21 July 2019

Click Here for more HEAT BIOLOGICS, INC. Charts.

Latest HTBX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.